Suzanne Shelley
Suzanne Shelley
Latest posts from :
Biosimilars: Poised for Takeoff?
Sue Naeyaert, Head, Global Pricing and Market Access Biosimilars, Merck Serono...
Payer-Reform for Physicians — ...
Dr Edward J. Benz, CEO of Dana Farber Cancer Institute discusses physician...